Movatterモバイル変換


[0]ホーム

URL:


WO2003041678A1 - Carotenoid composition and method for protecting skin - Google Patents

Carotenoid composition and method for protecting skin
Download PDF

Info

Publication number
WO2003041678A1
WO2003041678A1PCT/IL2002/000875IL0200875WWO03041678A1WO 2003041678 A1WO2003041678 A1WO 2003041678A1IL 0200875 WIL0200875 WIL 0200875WWO 03041678 A1WO03041678 A1WO 03041678A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
carotenoid
phytofluene
phytoene
lycopene
Prior art date
Application number
PCT/IL2002/000875
Other languages
French (fr)
Inventor
Morris Zelkha
Zohar Nir
Tanya Sedlov
Original Assignee
Lycored Natural Products Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP02803083.1ApriorityCriticalpatent/EP1443897B1/en
Priority to CA2467056Aprioritypatent/CA2467056C/en
Priority to JP2003543565Aprioritypatent/JP2005515179A/en
Priority to IL16170402Aprioritypatent/IL161704A0/en
Priority to ES02803083.1Tprioritypatent/ES2641737T3/en
Priority to BR0214197-3Aprioritypatent/BR0214197A/en
Application filed by Lycored Natural Products Industries Ltd.filedCriticalLycored Natural Products Industries Ltd.
Priority to US10/495,514prioritypatent/US20050053559A1/en
Priority to AU2002363613Aprioritypatent/AU2002363613B2/en
Publication of WO2003041678A1publicationCriticalpatent/WO2003041678A1/en
Priority to IL161704Aprioritypatent/IL161704A/en
Priority to NO20041803Aprioritypatent/NO20041803L/en
Priority to US12/406,762prioritypatent/US10420715B2/en

Links

Classifications

Definitions

Landscapes

Abstract

A method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof.

Description

Carotenoid Composition and Method for Protecting Skin
Field of the Invention
The present invention relates to the field of protection from sun radiation, particularly to methods and compositions effective in protecting skin.
Background of the Invention
It is well established that prolonged exposure to sun has damaging effects on the skin. Particularly, the uv radiation from the sun is known to cause erythema of the skin, sunburn and skin cancer. Protection of the skin from uv radiation can be achieved by protective attire as well as by protection in the form of topical compositions of various protective ingredients. A particular group of protective compositions are intended for oral administration. Oral compositions contain active ingredients which are delivered to the skin via an internal transport mechanism and thus protect the skin from uv radiation damage. A particular group of active ingredients which are suitable for use with said oral compositions are carotenoids. U.S. patent 3,920,834 describes the use of a mixture of carotenoids wherein cathaxanthin is the primary carotenoid in the composition. However, the use of cathaxanthin is known to be limited due to adverse effects it may have on pigmentation. U.S. patent 5,290,605 describes food-stuff and beverages intended for providing protection to the skin against uv sun radiation. Said foodstuff and beverages comprising carotenoids as well as ascorbic acid, tocopherols, coenzyme Q10 and reduced glutathione. U.S. patent 6,110,478 further describes a composition for protecting skin against uv radiation and the harmful effects thereof, wherein the composition contains a pro-vitamin A carotenoid and lycopene. The use of such a composition is limited by the negative effect pro-vitamin A carotenoids may have on the subject's health at certain dosage levels. An excess of vitamin A, which is produced in the body from pro-vitamin A carotenoids, was found to have adverse effects on health. Stahl et al ("Dietary Tomato Paste Protects against Ultraviolet Light-induced Erythema in Humans", Biochemical and Molecular Action of Nutrients, Research Communication, (2001) 1449-1451) have shown the protective effect of tomato paste which is known to contain inter alia lycopene, β- carotene and tocopherol, against uv light-induced erythema. However, Stahl has reported a problem in achieving desired carotenoid serum levels, suggesting poor bioavailability.
Accordingly, there is a long felt need to develop a composition for protecting skin against uv radiation which is suitable for oral administration and is safe at a wide range of dosages.
It is therefore a purpose of the present invention to provide a method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun.
A further purpose of the present invention is to provide a carotenoid composition effective in protecting the skin against the damages of uv radiation and which does present potential health risks.
It is yet another purpose of the present invention to provide a method and composition that overcome the disadvantages of the known art.
Other objectives of the invention will become apparent as the description proceeds.
Summary of the Invention The present invention provides a method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Optionally, said composition may further contain vitamin E.
Further provided by the present invention is a composition comprising of 6% to 25% lycopene of a natural source and more than 0.3% of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Optionally, said composition may contain 1% to 4% vitamin E. Further provided by the present invention is the use of a carotenoid composition containing lycopene from a natural source and one or more carotenoid selected from among a group consisting of phytoene and phytofluene as a protective agent against uv light-induced damage to skin. Optionally, said composition may further contain vitamin E.
The present invention further provides administration forms for the presently claimed composition, wherein said administration form may be a food-stuff, beverage or pharmaceutically acceptable dosage form.
Description of the Drawings
Fig. I - Comparison of protection of various carotenoid compositions against erythema
(see Example 2 for clarifications of terms appearing in graph)
Detailed Description of a Preferred Embodiment of the Invention
The following description is illustrative of embodiments of the invention. The following description is not to be construed as limiting, it being understood that the skilled person may carry out many obvious variations to the invention.
Throughout the description, percentages of components are by weight, unless specifically noted differently. The terms "lycopene of natural sources" and "natural lycopene" are synonymous throughout the application and refer to lycopene from vegetables, fruits, plant matter, fungus and fungal sources, and natural bio-mass.
It has surprisingly been found that carotenoid compositions which contain natural lycopene and one or more carotenoid selected from among a group consisting of phytoene and phytofluene, are effective in protecting skin against damages caused by uv radiation from the sun, wherein said damages are erythema and sunburn. Furthermore, unexpectedly, it has been found in the present invention that natural lycopene is significantly more effective in protecting skin against uv radiation damages than synthetic lycopene. A further surprising finding according to the present invention, is that the addition of phytoene and/or phytofluene to the natural lycopene composition improves the effectiveness of the composition in protecting skin against uv radiation damage.
According to an embodiment of the method of the present invention, 1 mg to 10 mg of a composition comprising 6% to 15% of natural lycopene and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene are administered to a subject. Preferably, about 5 mg of a composition comprising 6% of natural lycopene, 0.5% phytoene and 0.5% phytofluene are administered.
In yet a further embodiment of the present method the aforementioned compositions may contain 1.5% to 2.5% of vitamin E. preferably, said composition containing about 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
According to a particular embodiment of the invention, the compositions employed comprise natural lycopene and one or more additional carotenoid selected from among phytoene and phytofluene wherein the ratio between the lycopene and additional carotenoids is in the range of 20:1 to 5:1, preferably 8:1 to 5:1.
The indicated dosages refer to a healthy adult in the weight range of 50 Kg to 70 Kg and thus may vary according to body size. However, preferably, the dosage is adjusted so that the carotenoid serum level of the subject reaches a level within the range of 0.3 to 1.2 μM (micromole/liter), wherein serum levels of lycopene are 0.2 to 0.6 μM, phytoene 0.08 to 0.2 μM and phytofluene 0.08 to 0.4 μM. Dosages of total carotenoids may be daily in single or multiple doses, of about 2 to 15 mg/day, preferably 5 mg/day.
The compositions are administered by means known in the art, which will achieve the desired carotenoid serum levels. Oral administration is preferred. The oral administration can be in the form of a capsule, gel-cap, pellet, soft gel capsule or tablet which contain the carotenoid compositions. Said oral dosage forms may contain pharmaceutically acceptable excipients, additives, carriers and stabilizers. Particularly important additives are of the type which improve bioavailability of the carotenoids, e.g. oils and surfactants. Said oral dosage forms are prepared according to conventional methods known from the art. A preferred means of oral administration is via foodstuff and beverages. Thus, the carotenoid composition is added to foodstuff or beverages. The amount of carotenoid composition in the foodstuff and beverage is adjusted to meet the above-mentioned dosages.
According to a particular embodiment of the present method, administration of the composition is preferably started before exposure to uv radiation. Preferably, 7 to 30 days before exposure, and administration is continued during exposure.
According to a further aspect of the present invention there is provided a novel carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Preferably, the composition comprises 6% of natural lycopene, 0.5% phytoene and 0.5% phytofluene.
According to yet a further embodiment the composition may further comprise of 1.5% to 2.5% vitamin E. Preferably the composition contains 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
The compositions of the present invention comprise natural lycopene and one or more additional carotenoid selected from among a group consisting of phytoene and phytofluene wherein the ratio between the lycopene and additional carotenoid is in the range of 20:1 to 5:1, preferably 8:1 to 5:1. Optionally, the composition may further contain vitamin E wherein the ratio between the lycopene and the vitamin E is in the range of 10:1 to 2:1, preferably 8:1 to 3:1.
A particular embodiment of the present invention relates to solid and liquid oral dosage forms selected from among a group comprising of a capsule, gel-cap, pellet, soft gel capsule, tablet, or other liquid or solid oral dosage forms known in the art, which comprises a carotenoid composition which contains 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more additional carotenoid selected from among phytoene and/or phytofluene. Said oral dosage form may further comprise 1.5 mg to 8 mg of vitamin E. Preferably, said oral dosage form comprises 5 mg of natural lycopene, 0.5 mg phytoene, 0.45 mg phytofluene and 1.8 mg of vitamin E. Said dosage form may further contain a pharmaceutically acceptable adjuvant, excepient, carrier, filler, stabilizer or additive.
The present invention further relates to foodstuff or beverages which contains a carotenoid composition as described herein. The foodstuff or beverage contain 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Said food-stuff or beverage may further contain 1.5 mg to 8 mg of vitamin E. Preferably, said food-stuff or beverage comprises 4.1 mg of natural lycopene, 2.2 mg phytoene, 1.6 mg phytofluene and 3.8 mg of vitamin E.
The present invention presents the following advantages:
1. The compositions do not contain pro-vitamin A carotenoids, which at certain elevated dosages may be a health hazard. Thus, the present invention is safer and does not have the health risks as compositions described in the prior art.
2. The protection is provided via in- vivo activity. Thus, the protective composition cannot be washed away or depleted like topical protective compositions.
3. The compositions of the present invention have been shown to have improved bioavailability compared to other sources of natural lycopene and in comparison to synthetic lycopene, and thus offer improved protection against uv light-induced skin damage.
4. The composition may bring about tanning of the skin to a brown hue in subjects exposed to uv radiation without the damages associated with uv radiation. This has both health and aesthetic advantages. Examples
Example 1: Preparation of Carotenoid Composition
The lycopene used throughout the Examples is natural lycopene by LycoRed®.
Formulation 1 : each capsule contains:
Lycopene 4.88 mg Phytoene 0.48 mg
Phytofluene 0.44 mg
Vitamin E 1.81 mg in soft gel capsules which are prepared according to standard procedures known to the skilled artisan.
Formulation II: each soft drink bottle contains
Lycopene 4.1 mg
Phytoene 2.2 mg
Phytofluene 1.6 mg Vitamin E 3.8 mg
Formulation III Lycopene 5.5 mg Vitamin E 2.0 mg
Example 2: Comparative Example of Protection against erythema
Three treatment groups consumed the following lycopene supplements for 12 weeks: a) Group 1 - Lyc-O-Mato® soft gel capsules^ (1 capsule twice a day) b) Group 2 - Lyc-O-Guard™ drink2) (250 ml bottle twice a day) c) Group 3 - Synthetic lycopene hard shell capsules3) (1 capsule twice a day) 1) The carotenoid fraction is a tomato extract containing natural lycopene, phytoene, phytofluene and tocopherols. 2) The carotenoid fraction is a tomato extract similar to Lyc-O-Mato® which is further enriched with phytoene, phytofluene and tocopherols. 3) The carotenoid fraction contains synthetic lycopene and tocopherols.
The minimal erythema dose (MED), which is the minimal dose of uv radiation which produces a minimal erythema (reddening of the skin) after 24 hours was determined by exposing different small areas of skin to increasing doses of uv radiation. The testing of the effectiveness of the carotenoid supplementation was tested by exposing the subjects to 1.25 of the individual MED at 0, 4 and 12 weeks from the beginning of lycopene supplementation. The effect of the radiation on the reddening and pigmentation of the skin was measured by a Minolta chronometer. The "a" and "b" value of the chronometer correlate to the reddening and pigmentation of the skin, respectively. The erythema (reddening) was determined 24 hours after radiation of uv radiation, by subtracting the value of "a" before radiation from the value of "a" 24 hours after radiation. The value obtained is denoted by "Δa". Larger values of Δa correlate with increased erythema of the skin. Fig. 1 clearly demonstrates the improved protective effect against uv induced erythema, Lyc-O-Mato and Lyc-O- Guard have over synthetic lycopene.
While embodiments of the invention have been described by way of illustration, it will be apparent that the invention may be carried out with many modifications, variations and adaptations, without departing from its spirit or exceeding the scope of the claims.

Claims

1. A method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof.
2. A method according to claim 1 wherein said composition further contains vitamin E.
3. A method according to claim 1, wherein 1 mg to 10 mg of a carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof are administered.
4. A method according to claim 3 wherein said composition contains 1.5% to 2.5% vitamin E.
5. A method according to claim 3, wherein about 5 mg are administered.
6. A method according to claim 4, wherein about 5 mg are administered.
7. A method according to any of claims 1 to 6 wherein the carotenoid serum level of the subject reaches a level within the range of 0.3 to 1.5 μM.
8. A method according to claim 8 wherein carotenoid serum levels of the subject reaches a level of about 1.2 μM.
9. A method according to any one of claims 1 to 8 wherein administration is in the form of a capsule, gel-cap, pellet, soft gel capsule or tablet which contain the carotenoid compositions.
10. A method according to any one of claims 1 to 8 wherein administration is in the form of oral administration via foodstuff or beverages.
11. A method according to any one of claims 1 to 11 wherein administration begins 7 to 30 days before exposure to uv radiation.
12. A carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof.
13. A composition according to claim 12 further containing 1.5% to 2.5% vitamin E.
14. A composition according to claim 12 which contains about 6% natural lycopene, 0.5% phytoene and 0.5% phytofluene.
15. A composition according to claim 13 which contains about 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
16. An oral dosage form comprising of 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among phytoene and/or phytofluene or mixtures thereof.
17. An oral dosage form according to claim 16 further comprising 1.5 mg to 8 mg of vitamin E.
18. An oral dosage form according to claim 17 comprising 5 mg of natural lycopene, 0.5 mg phytoene, 0.45 mg phytofluene and 1.8 mg of vitamin E.
19. An oral dosage form according to claim 16 further containing a pharmaceutically acceptable adjuvant, excepient, carrier, filler, stabilizer or additive.
20. Use of a composition as described in any of claims 12 to 15 in the preparation of a skin protecting composition.
21. Use of a composition as described in any of claims 12 to 15 as a skin-protecting agent.
22. A composition according to any of claims 12 to 15 for use in the protection of skin against damages caused by uv radiation.
23. Foodstuff and beverage containing a composition as described in any of claims 12 to 15.
24. Foodstuff or beverage comprising of 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among a group consisting of phytoene and phytofluene.
25. Foodstuff or beverage according to claim 24 further comprising 1.5 mg to 8 mg of vitamin E.
26. Foodstuff or beverage according to claim 25 comprising 4.1 mg of natural lycopene, 2.2 mg phytoene, 1.6 mg phytofluene and 3.8 mg of vitamin E.
27. A pharmaceutically acceptable oral dosage form containing a composition as described in any of claims 12 to 15.
PCT/IL2002/0008752001-11-142002-11-05Carotenoid composition and method for protecting skinWO2003041678A1 (en)

Priority Applications (11)

Application NumberPriority DateFiling DateTitle
CA2467056ACA2467056C (en)2001-11-142002-11-05Carotenoid composition and method for protecting skin
JP2003543565AJP2005515179A (en)2001-11-142002-11-05 Carotenoid compositions and methods for protecting the skin
IL16170402AIL161704A0 (en)2001-11-142002-11-05Carotenoid composition and method for protecting skin
ES02803083.1TES2641737T3 (en)2001-11-142002-11-05 Carotenoid composition and method to protect the skin
BR0214197-3ABR0214197A (en)2001-11-142002-11-05 Method for protecting the skin against damage by solar UV radiation, carotenoid composition, oral dosage form containing lycopene and carotenoid and use
EP02803083.1AEP1443897B1 (en)2001-11-142002-11-05Carotenoid composition and method for protecting skin
US10/495,514US20050053559A1 (en)2001-11-142002-11-05Carotenoid composition and method for protecting skin
AU2002363613AAU2002363613B2 (en)2001-11-142002-11-05Carotenoid composition and method for protecting skin
IL161704AIL161704A (en)2001-11-142004-04-29Skin-protecting carotenoid composition
NO20041803ANO20041803L (en)2001-11-142004-05-03 Carotenoid preparation and skin protection method
US12/406,762US10420715B2 (en)2001-11-142009-03-18Carotenoid composition and method for protecting skin

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
IL14649601AIL146496A0 (en)2001-11-142001-11-14Carotenoid composition and method for protecting skin
IL1464962001-11-14

Related Child Applications (2)

Application NumberTitlePriority DateFiling Date
US10495514A-371-Of-International2002-11-05
US12/406,762ContinuationUS10420715B2 (en)2001-11-142009-03-18Carotenoid composition and method for protecting skin

Publications (1)

Publication NumberPublication Date
WO2003041678A1true WO2003041678A1 (en)2003-05-22

Family

ID=11075862

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PCT/IL2002/000875WO2003041678A1 (en)2001-11-142002-11-05Carotenoid composition and method for protecting skin

Country Status (15)

CountryLink
US (2)US20050053559A1 (en)
EP (1)EP1443897B1 (en)
JP (2)JP2005515179A (en)
KR (1)KR20050043788A (en)
CN (1)CN100391433C (en)
AU (1)AU2002363613B2 (en)
BR (1)BR0214197A (en)
CA (1)CA2467056C (en)
ES (1)ES2641737T3 (en)
IL (3)IL146496A0 (en)
NO (1)NO20041803L (en)
PL (1)PL209422B1 (en)
RU (1)RU2341252C2 (en)
WO (1)WO2003041678A1 (en)
ZA (1)ZA200403529B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP1508325A1 (en)*2003-08-212005-02-23Nestec S.A.Natural lycopene concentrate and process for producing the same
US7271296B2 (en)2003-10-242007-09-18Basf AktiengesellschaftMethod for the production of phytofluene
WO2008004206A3 (en)*2006-07-022008-04-17Ibr LtdCarotenoid compositions useful for whitening skin
CN104188812A (en)*2014-09-022014-12-10青岛永通电梯工程有限公司Physical sunscreen cream
CN104323936A (en)*2014-09-302015-02-04青岛康和食品有限公司Sunblocking cream
US9579298B2 (en)2004-12-022017-02-28Piotr ChomczynskiAntioxidant dietary supplement compositions and methods for maintaining healthy skin
WO2022268941A1 (en)2021-06-242022-12-29Norwegian University Of Science And Technology (Ntnu)Therapeutic methods and devices

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
IL141039A (en)*2001-01-232006-10-31Lycored Natural Prod Ind LtdAnti-atherosclerosis composition containing carotenoids and use in the preparation of medicaments for inhibiting ldl oxidation
US20080287508A1 (en)*2007-05-182008-11-20Intermune, Inc.Altering pharmacokinetics of pirfenidone therapy
FR2985064B1 (en)*2011-12-232016-02-26Oreal METHOD FOR DELIVERING COSMETIC ADVICE
JP6012415B2 (en)*2012-11-092016-10-25アサヒグループホールディングス株式会社 Drunkenness reducing agent
CN103536506A (en)*2013-10-152014-01-29倪生标Sunscreen lotion
CN108379563A (en)*2018-05-142018-08-10青岛琛蓝海洋生物工程有限公司A kind of radiation protection composition and preparation method thereof
BR112021001328A2 (en)2018-07-232021-04-20Lycored Ltd. lycopene compositions and methods to protect the skin from ultraviolet radiation
WO2021070184A1 (en)*2019-10-102021-04-15Lycored Ltd.Compositions and methods for inhibiting collagen loss
JP2023534587A (en)*2020-05-072023-08-10ライコレッド リミテッド. High prolycopene composition and method of using same

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5290605A (en)*1989-06-291994-03-01Niva ShapiraSun-exposure nutritional supporting composition
WO2000013654A2 (en)*1998-09-042000-03-16I.B.R. Israeli Biotechnology Research, Ltd.A carotenoid composition containing phytoene and phytofluene
US6110478A (en)*1996-06-122000-08-29Laboratoire OenobiolComposition having tanning and photoprotective activity, and its cosmetic applications
WO2002058683A2 (en)*2001-01-232002-08-01Lycored Natural Products Industries Ltd.Carotenoids as anti-hypertension agents

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3920834A (en)*1970-07-101975-11-18Hoffmann La RocheLight-screening compositions and method
US6132790A (en)*1991-09-062000-10-17Betatene LimitedCarotenoid composition
RU2058133C1 (en)*1992-06-241996-04-20Парфюмерно-косметическая фабрика "Виорика"Face cream
FR2698268B1 (en)*1992-11-241995-01-20Oreal Photoprotective composition administered orally.
US5643623A (en)*1995-06-071997-07-01Mars IncorporatedHealth food product and its uses
IL118697A (en)*1996-06-201999-12-31Lycored Natural Prod Ind LtdIndustrial processing of tomatoes
US6110748A (en)*1997-04-302000-08-29Motorola, Inc.Optical storage medium for binding assays
DK0938846T3 (en)1998-02-132004-06-14Nestle Sa Garnished toast
FR2805742B3 (en)*2000-03-032002-05-10I B R Isareli Biotechnology Re COLORLESS PREPARATION COMPRISING CAROTENOIDS
RU2271213C2 (en)*2000-05-122006-03-10Бенгт Кристер ОЛЬСОНCombined compositions containing plant and sea animal extracts
WO2003068202A1 (en)2002-02-152003-08-21Dsm Ip Assets B.V.Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
JP2006510647A (en)2002-12-062006-03-30ディーエスエム アイピー アセッツ ビー.ブイ. New uses for lycopene
JP5686496B2 (en)2005-09-302015-03-18富士化学工業株式会社 Metabolic syndrome improvement / prevention composition
EP2020997A2 (en)2006-05-152009-02-11DSMIP Assets B.V.Novel actives against prostate carcinoma
IL184575A0 (en)2007-07-122008-01-20Lycored LtdSynergistic combinations for treating hypertension
BRPI1005154A2 (en)2009-01-192018-02-06Lycored Ltd "therapeutic composition, method for inhibiting or reducing the production of superoxide ions, nitric oxide (n), tumor necrosis factor alpha (tnf-alpha) and / or prostaglandin e2 (pge2) in a mammalian subject, methods of treatment and use of a combination"
JP2010208972A (en)2009-03-092010-09-24Kao CorpEndothelin expression inhibitor
US20110111055A1 (en)2009-11-062011-05-12Alcon Research, Ltd.Nutritional supplements for relief of dry eye
WO2014147610A1 (en)2013-03-192014-09-25Lycored Ltd.Astaxanthin anti-inflammatory synergistic combinations

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5290605A (en)*1989-06-291994-03-01Niva ShapiraSun-exposure nutritional supporting composition
US6110478A (en)*1996-06-122000-08-29Laboratoire OenobiolComposition having tanning and photoprotective activity, and its cosmetic applications
WO2000013654A2 (en)*1998-09-042000-03-16I.B.R. Israeli Biotechnology Research, Ltd.A carotenoid composition containing phytoene and phytofluene
WO2002058683A2 (en)*2001-01-232002-08-01Lycored Natural Products Industries Ltd.Carotenoids as anti-hypertension agents

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ABOUT LYC-O-MATO TM, XP002233574, Retrieved from the Internet <URL:http://www.lycomato.com/> [retrieved on 20030305]*
HEALTY ORIGINS-LYC-O-MATO CLINICAL TRIO LYCOPENE, 60 SOFTGELS, XP002233575, Retrieved from the Internet <URL:http://www.lifesvigor.com/products/378105.html> [retrieved on 20030305]*
I. PAETAU ET AL.: "Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentratios of lycopene and related tomato carotenoids in humans", AMERICAN JOURNAL OF CLINICAL NUTRITION, vol. 68, 1998, pages 1187 - 1195, XP002233573*
O. KUCUK ET AL.: "Phase II Randomized Clinical Trial of Lycopene Supplementation before Radical Prostatectomy", CANCER EPIDEMOLOGY, BIOMARKERSŸPREVENTION, vol. 10, August 2001 (2001-08-01), pages 861 - 868, XP002233572*
W. STAHL ET AL.: "Dietary Tomato Paste Protects against Ultraviolet Light Induced Erythema in Humans", JOURNAL OF NUTRITION, vol. 131, 2001, pages 1449 - 1451, XP002233576*

Cited By (15)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US8795743B2 (en)2003-08-212014-08-05Nestec S.A.Natural lycopene concentrate and method for production thereof
US8507014B2 (en)2003-08-212013-08-13Nestec S.A.Natural lycopene concentrate and method for production thereof
JP2007502800A (en)*2003-08-212007-02-15ネステク ソシエテ アノニム Natural lycopene concentrate and production method
AU2004267942B2 (en)*2003-08-212009-10-08Nestec S.A.Natural lycopene concentrate and method for production therof
WO2005020948A1 (en)*2003-08-212005-03-10Nestec S.A.Natural lycopene concentrate and method for production therof
JP4814094B2 (en)*2003-08-212011-11-09ネステク ソシエテ アノニム Natural lycopene concentrate and production method
EP1508325A1 (en)*2003-08-212005-02-23Nestec S.A.Natural lycopene concentrate and process for producing the same
US7271296B2 (en)2003-10-242007-09-18Basf AktiengesellschaftMethod for the production of phytofluene
US9827208B2 (en)2004-12-022017-11-28Pior ChomczynskiAntioxidant dietary supplement compositions and methods for maintaining healthy skin
US9579298B2 (en)2004-12-022017-02-28Piotr ChomczynskiAntioxidant dietary supplement compositions and methods for maintaining healthy skin
US8398958B2 (en)2006-07-022013-03-19I.B.R. Israeli Biotechnology Research Ltd.Carotenoid compositions useful for whitening skin
WO2008004206A3 (en)*2006-07-022008-04-17Ibr LtdCarotenoid compositions useful for whitening skin
CN104188812A (en)*2014-09-022014-12-10青岛永通电梯工程有限公司Physical sunscreen cream
CN104323936A (en)*2014-09-302015-02-04青岛康和食品有限公司Sunblocking cream
WO2022268941A1 (en)2021-06-242022-12-29Norwegian University Of Science And Technology (Ntnu)Therapeutic methods and devices

Also Published As

Publication numberPublication date
PL209422B1 (en)2011-08-31
AU2002363613B2 (en)2007-08-02
KR20050043788A (en)2005-05-11
CA2467056A1 (en)2003-05-22
ZA200403529B (en)2005-01-12
CN1585629A (en)2005-02-23
RU2004114283A (en)2005-03-20
RU2341252C2 (en)2008-12-20
CA2467056C (en)2014-11-04
US20090176872A1 (en)2009-07-09
EP1443897B1 (en)2017-07-12
JP2012180363A (en)2012-09-20
PL368855A1 (en)2005-04-04
IL146496A0 (en)2002-07-25
US20050053559A1 (en)2005-03-10
US10420715B2 (en)2019-09-24
ES2641737T3 (en)2017-11-13
IL161704A0 (en)2004-09-27
JP2005515179A (en)2005-05-26
EP1443897A1 (en)2004-08-11
BR0214197A (en)2004-08-31
CN100391433C (en)2008-06-04
JP6125760B2 (en)2017-05-10
NO20041803L (en)2004-08-06
IL161704A (en)2015-11-30

Similar Documents

PublicationPublication DateTitle
US10420715B2 (en)Carotenoid composition and method for protecting skin
AU2002363613A1 (en)Carotenoid composition and method for protecting skin
US7588785B2 (en)Methods and kits for reducing cellular damage, inhibiting free radical production and scavenging free radicals
KR100539633B1 (en)Nutritional Supplement to Treat Macular Degeneration
US20050249821A1 (en)Nutritional supplement for treatment of ocular diseases
US20040219239A1 (en)Nutritional supplement based on blackcurrent seed oil
KR20080045083A (en) How to suppress light-induced skin carcinogenesis
US20080171032A1 (en)Dietary supplement composition and method of use for the treatment and prevention of oxidative stress
US20040259959A1 (en)Method and pharmaceutical preparation for reducing the activity of cells
US5948823A (en)Irradiation protection method
AU772825B2 (en)Sunscreen agent for oral administration
US20080014156A1 (en)Photoprotectant composition for preventing sunburn and sun damage to the skin
EP0712630A2 (en)Oral composition for the prevention of sun allergies containing a carotenoid, a tocopherol, ascorbic acid and selenium
Singh et al.Antioxidants the powerful new weapons in the fight against periodontal diseases
Afshar et al.Endogenous Antioxidant Photoprotection and Its Enhancement in Human Skin
SmithImmunomodulation and Antioxidant Nutraceuticals
EP2952104A1 (en)Composition and method for preventing damage of human cells by ionising radiation
Kornhauser et al.β-Carotene Protection Against Phototoxicity In Vivo
Kedia et al.Shivani oxivore with wealth of benefits”
AU2002348711A1 (en)Method and pharmaceutical preparations for reducing the activity of cells
IES68517B2 (en)Anti-oxidant formulations

Legal Events

DateCodeTitleDescription
AKDesignated states

Kind code of ref document:A1

Designated state(s):AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

ALDesignated countries for regional patents

Kind code of ref document:A1

Designated state(s):GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121Ep: the epo has been informed by wipo that ep was designated in this application
DFPERequest for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWEWipo information: entry into national phase

Ref document number:161704

Country of ref document:IL

WWEWipo information: entry into national phase

Ref document number:00576/KOLNP/2004

Country of ref document:IN

Ref document number:576/KOLNP/2004

Country of ref document:IN

WWEWipo information: entry into national phase

Ref document number:2004/03529

Country of ref document:ZA

Ref document number:200403529

Country of ref document:ZA

WWEWipo information: entry into national phase

Ref document number:2467056

Country of ref document:CA

Ref document number:1020047007216

Country of ref document:KR

WWEWipo information: entry into national phase

Ref document number:20028224841

Country of ref document:CN

Ref document number:2003543565

Country of ref document:JP

REEPRequest for entry into the european phase

Ref document number:2002803083

Country of ref document:EP

WWEWipo information: entry into national phase

Ref document number:2002803083

Country of ref document:EP

WWEWipo information: entry into national phase

Ref document number:2002363613

Country of ref document:AU

WWPWipo information: published in national office

Ref document number:2002803083

Country of ref document:EP

WWEWipo information: entry into national phase

Ref document number:10495514

Country of ref document:US


[8]ページ先頭

©2009-2025 Movatter.jp